LAURALEE SPRAGUE: Open Payments
NPI 1508820374 · SPRINGVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 48 payments from 18 companies in 2025. Trend: 2023 $1,077 · 2024 $834 · 2025 $1,040
Food & beverage: $1,040
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $108 |
| Boston Scientific Corporation | 5 | $104 |
| ABIOMED | 4 | $103 |
| PFIZER INC. | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| Abbott Laboratories | 1 | $70 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| Novo Nordisk Inc | 3 | $50 |
| Edwards Lifesciences Corporation | 2 | $45 |
Products named: ELIQUIS, JARDIANCE, CAMZYOS, GALLANT, VERQUVO, WATCHMAN, ONPATTRO, Wegovy.
Industry payments across NY — which companies pay providers there.
